Our findings demonstrate that mTOR activity promotes fibrosis and liver disease in Otulin∆hep mice, but also that mTOR inhibition by rapamycin is insufficient to completely prevent liver pathology in these mice. This evidence concerns the gene MTOR and liver disorder.